Gaithersburg, MD, United States of America

Russell J McCandliss


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1993-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Russell J McCandliss in Gaithersburg, MD

Introduction

Russell J McCandliss is an accomplished inventor based in Gaithersburg, MD, known for his significant contributions to the field of biotechnology. With a total of three patents to his name, McCandliss has focused his work on developing innovative solutions in the area of vaccines and immunology. His research has set new standards in the fight against avian coccidia, showcasing his dedication to advancing scientific knowledge and public health.

Latest Patents

McCandliss's most recent patents highlight his expertise and innovative spirit. The first is titled "Isolated protein from Eimeria useful as a cross species vaccine." This patent involves a cloned gene or fragment that encodes antigenic proteins specifically designed to interact with monoclonal or polyvalent antibodies targeting antigenic proteins of avian coccidia. The second patent, "25 KD coccidial antigen of Eimeria tenella," also concerns a cloned gene or fragment that performs a similar role in binding with antibodies against avian coccidia. These advancements are critical for developing effective vaccines and enhancing animal health.

Career Highlights

Throughout his career, McCandliss has worked with notable organizations, including Enzon, Inc. and the U.S. Department of Agriculture. His roles in these companies allowed him to dive deep into research and development, paving the way for successful innovations in vaccine technology. His dedication and expertise have established him as a prominent figure in the field of biotechnology.

Collaborations

Russell J McCandliss has collaborated with esteemed colleagues such as David M Anderson and Susan L Strausberg. These partnerships have enriched his research, merging diverse expertise to tackle complex challenges in the development of vaccines and improving overall health in avian species.

Conclusion

In summary, Russell J McCandliss stands out as an inventive force in biotechnology, especially in the realm of vaccine development for avian coccidia. His patents illustrate a profound understanding of immunology and a commitment to innovation. As he continues to explore new frontiers in research, the contributions of McCandliss will undoubtedly have lasting impacts on animal health and veterinary medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…